BK Viremia is Common in Children after Allogeneic Hematopoietic Cell Transplant

被引：0
|
作者：
Laskin, Benjamin [1 ]
Seif, Alix E. [2 ]
Bunin, Nancy J. [2 ]
Wang, Yongping [3 ]
Beier, Ulf [1 ]
Altrich, Michelle [4 ]
Kleiboeker, Steve [4 ]
Jodele, Sonata [5 ]
Davies, Stella M. [6 ]
Denburg, Michelle [1 ]
机构：
[1] Childrens Hosp Philadelphia, Nephrol, Philadelphia, PA 19104 USA
[2] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA
[3] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA USA
[4] Viracor Eurofins, Lees Summit, MO USA
[5] Childrens Hosp Los Angeles, Hematol Oncol & Blood & Marrow Transplantat, Los Angeles, CA 90027 USA
[6] Cincinnati Childrens Hosp Med Ctr, Bone Marrow Transplantat & Immune Deficiency, Cincinnati, OH 45229 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2018年 / 24卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
85
引用
收藏
页码：S82 / S82
页数：1
相关论文
共 50 条
  • [41] Vitamin D Level after Allogeneic Hematopoietic Stem Cell Transplant
    Sproat, Lisa
    Bolwell, Brian
    Rybicki, Lisa
    Dean, Robert
    Sobecks, Ronald
    Pohlman, Brad
    Andresen, Steven
    Sweetenham, John
    Copelan, Edward
    Kalaycio, Matt
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (07) : 1079 - 1083
  • [42] Leukemia in donor cells after allogeneic hematopoietic stem cell transplant
    Brunstein, CG
    Hirsch, BA
    Hammerschmidt, D
    McGlennen, RC
    Nguyen, PL
    Verfaillie, CM
    BONE MARROW TRANSPLANTATION, 2002, 29 (12) : 999 - 1003
  • [43] Is anemia a harbinger of poorer outcomes after allogeneic hematopoietic cell transplant?
    Kindwall-Keller, Tamila L.
    Ballen, Karen K.
    BONE MARROW TRANSPLANTATION, 2020, 55 (02) : 275 - 277
  • [44] Autoimmune thyroid dysfunction after allogeneic hematopoietic stem cell transplant
    Isshiki, Yusuke
    Ono, Keiko
    Shono, Katsuhiro
    Onoda, Masahiro
    Yokota, Akira
    LEUKEMIA & LYMPHOMA, 2016, 57 (05) : 1227 - 1229
  • [45] Comparison of Outcomes After Second Allogeneic Hematopoietic Cell Transplantation Versus Donor Lymphocyte Infusion in Allogeneic Hematopoietic Cell Transplant
    Al-Shaibani, Eshrak
    Bautista, Rhida
    Lipton, Jeffrey H.
    Kim, Dennis D.
    Viswabandya, Auro
    Kumar, Rajat
    Lam, Wilson
    Law, Arjun D.
    Al-Shaibani, Zeyad
    Gerbitz, Armin
    Pasic, Ivan
    Mattsson, Jonas
    Michelis, Fotios, V
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (05): : E327 - E334
  • [46] Is anemia a harbinger of poorer outcomes after allogeneic hematopoietic cell transplant?
    Tamila L. Kindwall-Keller
    Karen K. Ballen
    Bone Marrow Transplantation, 2020, 55 : 275 - 277
  • [47] Evaluation of prolonged magnesium infusion after allogeneic hematopoietic cell transplant
    Seago, Kelsea
    Goodner, Joshua A.
    Dillaman, Megan
    Wen, Sijin
    Veltri, Lauren
    Ross, Kelly G.
    Cumpston, Aaron
    SUPPORTIVE CARE IN CANCER, 2024, 32 (01)
  • [48] Evaluation of prolonged magnesium infusion after allogeneic hematopoietic cell transplant
    Kelsea Seago
    Joshua A. Goodner
    Megan Dillaman
    Sijin Wen
    Lauren Veltri
    Kelly G. Ross
    Aaron Cumpston
    Supportive Care in Cancer, 2024, 32
  • [49] Clinical Consequences Associated with BK Virus Infection among Allogeneic Hematopoietic Cell Transplant (HCT) Recipients
    Mozaffari, E.
    Lee, Y. -C.
    Tao, B.
    Casciano, R.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S203 - S203
  • [50] Functional specific-T-cell expansion after first cytomegalovirus reactivation predicts viremia control in allogeneic hematopoietic stem cell transplant recipients
    Ciaurriz, Miriam
    Beloki, Lorea
    Zabalza, Amaya
    Bandres, Eva
    Mansilla, Cristina
    Perez-Valderrama, Estela
    Lachen, Mercedes
    Rodriguez-Calvillo, Mercedes
    Ramirez, Natalia
    Olavarria, Eduardo
    TRANSPLANT INFECTIOUS DISEASE, 2017, 19 (06)
12345